Summary: Mutation of the FMR1 gene, known for causing Fragile X syndrome, is also linked to premature ovarian failure (POF). New research shows this mutation alters neurons that control reproductive function in both the brain and the ovaries, helping explain early infertility in affected women.
Source: UCR
Researchers at the University of California, Riverside have uncovered neural mechanisms that help explain how FMR1 gene mutations lead to reproductive failure. The same FMR1 mutation that causes Fragile X syndrome—one of the most common single-gene causes of intellectual disability and autism—also increases the risk of early ovarian aging and infertility in women.
Mutations in the Fragile X messenger ribonucleoprotein 1 gene (FMR1) have long been associated with a markedly higher risk of premature ovarian failure (POF), but the biological reasons were not fully understood. The UCR team found that FMR1 mutations alter the structure and activity of neurons that regulate reproduction, producing changes in hormonal signaling from both the hypothalamus and the ovary.
POF represents the most extreme form of premature ovarian aging. Affecting roughly 10% of women in some categories, POF is characterized by early depletion of ovarian follicles and early menopause. As more women delay childbearing, genetic factors such as FMR1 mutations become increasingly relevant to fertility planning and reproductive health.
“Over the last several decades the median age of first-time mothers in the U.S. and Europe has steadily risen,” said Djurdjica Coss, professor of biomedical sciences at the UCR School of Medicine and lead author on the study. “Premature menopause not only causes early infertility but also raises long-term risks for cardiovascular disease and osteoporosis. Understanding the underlying causes is essential for developing treatments and for advising women at risk about family planning and health monitoring.”
Public health data indicate infertility affects a substantial share of couples: about 19% of heterosexual couples in the U.S. at some point require assisted reproductive technologies, which may be costly or inaccessible for many. Identifying genetic contributors such as FMR1 can improve diagnosis and inform strategies for preserving fertility.
Previous investigations into FMR1-related reproductive disorders focused primarily on endocrine changes—how hormone levels and ovarian endocrine cells are affected. The UCR team approached the problem from a different perspective. Because the FMR1 gene is highly expressed in neurons, they hypothesized that neuronal circuits controlling reproduction might be directly affected by the mutation, producing downstream hormonal imbalances.
Their experiments confirmed this hypothesis. Using transgenic mice lacking the Fmr1 gene to model the human mutation, the researchers documented changes in both hypothalamic neurons that control reproductive hormone release and in the pattern of nerve supply to the ovaries. These neuronal alterations led to elevated hormone secretion in young mutant females and ultimately to early cessation of reproductive function—paralleling observations in women with the FMR1 mutation.
To isolate neural contributions from ovarian feedback, the team also performed ovariectomies on the mice. This allowed them to show that gonadotropin-releasing hormone (GnRH) neurons in the hypothalamus exhibit altered connectivity and increased excitability independent of ovarian signals. Specifically, GnRH neurons in mutant mice had more synapses and higher levels of synaptic proteins, which produced faster and more frequent pulses of hormone release.
At the same time, the ovaries of Fmr1-null mice showed increased innervation: more sympathetic nerve fibers and greater vascularization of corpora lutea. The investigators interpret these changes as drivers of elevated ovarian hormone output in young mutant females. Rather than an increase in the number of hormone-producing endocrine cells, the data point to altered neural input that increases ovarian activity, contributing to early follicle depletion and premature reproductive failure.
The study therefore implicates two interrelated mechanisms in FMR1-mediated reproductive dysfunction: hyperactive GnRH neurons in the hypothalamus and increased sympathetic innervation of the ovary. Both pathways likely work together to raise gonadotropin and ovarian hormone levels early in life, accelerating ovarian aging.
Looking ahead, Coss and colleagues plan to test whether reducing neuronal activity in the ovary can normalize hormone levels and extend reproductive lifespan in affected animals. If partial inhibition of ovarian innervation proves effective, it may suggest new therapeutic targets to delay or prevent POF in women with FMR1 mutations.
Coss led the work with collaborators Pedro A. Villa, Nancy M. Lainez, Carrie R. Jonak, Sarah C. Berlin, and Iryna M. Ethell. The study was published in Frontiers in Endocrinology and funded by a grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development at the National Institutes of Health.
About this ASD and genetics research news
Author: Iqbal Pittalwala
Source: UCR
Contact: Iqbal Pittalwala – UCR
Image: The image is in the public domain
Original Research: Open access. “Altered GnRH neuron and ovarian innervation characterize reproductive dysfunction linked to the Fragile X messenger ribonucleoprotein (Fmr1) gene mutation” by Djurdjica Coss et al., Frontiers in Endocrinology
Abstract
Altered GnRH neuron and ovarian innervation characterize reproductive dysfunction linked to the Fragile X messenger ribonucleoprotein (Fmr1) gene mutation
Introduction: Mutations in the FMR1 gene cause Fragile X Syndrome, a leading monogenic cause of intellectual disability. These mutations are also associated with reproductive disorders in females, including early loss of reproductive function. While the neurological basis of cognitive symptoms has been extensively studied, the neuronal role in FMR1-related reproductive dysfunction has been underexplored.
Results: Female Fmr1-null mice mirror human FMR1 mutation carriers by ceasing reproduction early. Young mutant females, however, produce larger litters and show more corpora lutea, alongside elevated circulating inhibin, progesterone, testosterone, and gonadotropins. Both hypothalamic changes and ovarian factors contribute to the elevated gonadotropins. The hypothalamus displays altered expression of synaptic molecules, consistent with dysregulated GnRH neuron function. The ovaries show increased vascularization and sympathetic innervation, and GnRH neurons have more excitatory GABAA receptor synapses—changes that drive higher follicle-stimulating hormone (FSH) and luteinizing hormone (LH) secretion. Mutant mice, whether ovariectomized or intact, exhibit increased LH pulse frequency, indicating hyperactive GnRH neurons independent of ovarian feedback.
Conclusion: The findings demonstrate that Fmr1 influences GnRH neuron secretion and that both altered hypothalamic function and increased ovarian innervation contribute to Fmr1-mediated reproductive disorders. These insights reveal neural targets that may be considered for future interventions to prevent or delay premature ovarian failure associated with FMR1 mutations.